Literature DB >> 23974648

[Atrial fibrillation in the ICU. Distinct entity--special treatment?].

G Heinz1.   

Abstract

Atrial fibrillation (AF) is the single most frequent arrhythmia in the intensive care unit, occurring among 44-61 % of all patients with arrhythmias in the intensive care unit. The success rate of electrical cardioversion (DC-CV) early after surgery is as low as 10-35 % in postoperative AF but 6 weeks after discharge 90 % are in sinus rhythm (SR). Several guidelines recommend rate control in these patients and rate control with β-blockers and calcium channel blockers is not inferior with respect to outcome, 6 min walk test, and quality of life. DC-CV is recommended in unstable and heart failure patients. The term resistant AF is suggested for that distinct situation of AF not amenable to cardioversion solely in the acute phase of critical illness.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23974648     DOI: 10.1007/s00063-012-0141-y

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  34 in total

1.  Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.

Authors:  A Capucci; G Q Villani; D Aschieri; A Rosi; M F Piepoli
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

2.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  Arrhythmias in the ICU: what do we know?

Authors:  Gottfried Heinz
Journal:  Am J Respir Crit Care Med       Date:  2008-07-01       Impact factor: 21.405

4.  Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study.

Authors:  H Knotzer; A Mayr; H Ulmer; W Lederer; W Schobersberger; N Mutz; W Hasibeder
Journal:  Intensive Care Med       Date:  2000-07       Impact factor: 17.440

5.  A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.

Authors:  A John Camm; Alessandro Capucci; Stefan H Hohnloser; Christian Torp-Pedersen; Isabelle C Van Gelder; Brian Mangal; Gregory Beatch
Journal:  J Am Coll Cardiol       Date:  2011-01-18       Impact factor: 24.094

6.  Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.

Authors:  G Delle Karth; A Geppert; T Neunteufl; U Priglinger; M Haumer; M Gschwandtner; P Siostrzonek; G Heinz
Journal:  Crit Care Med       Date:  2001-06       Impact factor: 7.598

7.  Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery.

Authors:  E G Daoud; S A Strickberger; K C Man; R Goyal; G M Deeb; S F Bolling; F D Pagani; C Bitar; M D Meissner; F Morady
Journal:  N Engl J Med       Date:  1997-12-18       Impact factor: 91.245

8.  Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?

Authors:  U Priglinger; G Delle Karth; A Geppert; C Joukhadar; S Graf; R Berger; M Hülsmann; S Spitzauer; I Pabinger; G Heinz
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

9.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

10.  Re-evaluating high-frequency oscillation for ARDS: Would a targeted approach be successful?

Authors:  Ewan C Goligher; Niall D Ferguson
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.